Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

NCT03283670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major
Depressive Disorder, Treatment-Resistant

Interventions

DRUG: Nitrous Oxide 25%
DRUG: Nitrous Oxide 50%
DRUG: Placebo Gas

Sponsor

Washington University School of Medicine

Collaborators

[object Object]